The Oncolytic Virus Therapy Market involves the use of viruses that preferentially infect and kill cancer cells. Oncolytic viruses infect and replicate inside cancer cells, resulting in the destruction of the cancer cells. These viruses do not replicate in normal cells. Common viruses used in oncolytic virus therapy include adenovirus, herpes simplex virus, reovirus, parvovirus, Newcastle disease virus, and Vaccinia virus. Oncolytic virus therapy has advantages over traditional cancer therapies as it is highly selective and eliminates only cancerous cells without damaging healthy cells. The need for oncolytic virus therapy is growing owing to the drawbacks associated with traditional chemotherapy and radiation therapy such as harmful side effects and limited effectiveness.

The Global Oncolytic Virus Therapy Market is estimated to be valued at US$ 10.82 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Oncolytic Virus Therapy are Albea, Amcor , Essel Propack, Huhtamaki, Montebello Packaging, Sonoco Products, ALLTUB, Linhardt, Auber Packaging, Antilla Propack, Universal Metal Products, DNIndustries, Perfect Containers, Jiujiang Deshun Adhesives, Andpak, CONSTRUCT Packaging, Adelphi Healthcare Packaging, IntraPac International, Hubei Xin Ji Pharmaceutical Packaging, World Wide Packaging. The increasing prevalence of cancer worldwide is driving the demand for effective treatment options. Oncolytic virus therapy has emerged as a promising approach and is gaining popularity as it can target cancer cells without harming normal cells.

The Oncolytic Virus Therapy Market Trends is expected to rise significantly in the coming years due to rapidly aging population, urbanization, and changing lifestyle habits such as smoking. According to WHO, the global cancer burden is projected to increase by 50% by 2040. This growing prevalence of cancer cases globally is expected to boost the demand for oncolytic virus therapy during the forecast period.

Many biotech and pharmaceutical companies are focusing on research and development of oncolytic viruses to expand the pipeline of products. Several companies are engaged in clinical trials for various virus therapies for different cancer types. In addition, collaborations between industry players and research institutes are helping drive innovation. This is expected to fuel the expansion of the global oncolytic virus therapy market.

Get More Insights on, Oncolytic Virus Therapy Market